Axiostat
Commercial- Indications
- Bleeding control, Vascular closure, Surgical hemostasis
Company intelligence / Profile preview
Axio Biosolutions
Bengaluru, Karnataka, Indiaaxiobio.com ↗
- Ownership
- Private
- Employees
- ~200
- Development stage
- Commercial
01
Overview
Axio Biosolutions has developed and commercialized a range of advanced wound care and hemostatic products. Their flagship product Axiostat—a chitosan-based hemostatic dressing—has received US FDA and CE approval for instant bleeding control. MaxioCel is another next-generation chitosan-based dressing for chronic wound management. The company’s products are used globally in trauma care (including military), surgery, emergency medicine, disaster relief, and chronic wound management[1][2].
- Therapeutic areas
- OtherDermatologyOncologyInfectious Diseases
- Modalities
- DeviceBiologic (chitosan-based)
- Industry
- Consumable Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
No major pharma partnerships disclosed publicly as of June 2025.
Beyond the preview
Go deeper on Axio Biosolutions.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Axio Biosolutions.